Mechanotransduction in cancer.

Area of Science:

• Biomedical Engineering
• Cancer Biology
• Cell Mechanics

Background:

• Tissue stiffness is regulated in normal conditions but altered in disease, notably in cancer where tumors stiffen while cancer cells soften.
• Increasing evidence highlights the extracellular matrix (ECM) stiffness's role in modulating cancer and stromal cell mechanics and function.
• ECM stiffness influences critical cancer hallmarks such as angiogenesis, migration, and metastasis.

Purpose of the Study:

• To review recent studies on cancer and stromal cell responses to ECM stiffness.
• To explore the sensing mechanisms and signaling pathways involved in mechanotransduction.
• To discuss novel biomaterial substrates that replicate the in vivo mechanical environment of cancer cells.

Main Methods:

• Literature review of recent studies on cell mechanics and ECM interactions.
• Analysis of cellular responses to varying substrate stiffness.
• Examination of signaling pathways and molecular mechanisms of mechanosensing.

Main Results:

• Cancer and fibrosis-relevant stromal cells exhibit distinct responses to ECM stiffness.
• Specific cell surface receptors and intracellular signaling pathways mediate the sensing of ECM mechanical properties.
• Novel substrate designs, including those with fractal heterogeneity, effectively mimic the in vivo tumor microenvironment.

Conclusions:

• ECM stiffness is a critical regulator of cancer cell behavior and disease progression.
• Understanding cell-ECM mechanical interactions is vital for developing targeted cancer therapies.
• Advanced biomaterials that recapitulate in vivo mechanical cues offer promising tools for cancer research and therapeutic development.